Skip to main content
Report an Issue

Institutional Biosafety Committee (IBC)

Quick Links

The mission of the IBC is to ensure that all recombinant or synthetic nucleic acid molecules research conducted at the institution or sponsored by the institution is conducted in compliance with the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines). The purpose of the NIH Guidelines is to specify the practices for constructing and handling: 

  • Recombinant nucleic acid molecules
  • Synthetic nucleic acid molecules, including those that are chemically or otherwise modified but can base pair with naturally occurring nucleic acid molecules
  • Cells, organisms, and viruses containing such molecules
IBC Members

The Duke IBC membership includes individuals representing a variety of scientific disciplines.  This diverse group was selected to provide the appropriate oversight of the various types of rDNA research conducted at Duke. If you are interested in joining the IBC or have questions, please feel free to contact

The current IBC Co-Chairs are:

Dr. Richard Frothingham
Ph: 919-684-5455

Dr. Matthew Stiegel
Ph: 919- 681-4219



IBC Meetings

Submission Deadlines and Meetings